JXOClass II
Enzyme Immunoassay, Cocaine
21 CFR 862.3250 / Clinical Toxicology
JXO is the FDA product code for Enzyme Immunoassay, Cocaine, a class II device type, regulated under 21 CFR 862.3250. As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- JXO
- Device name
- Enzyme Immunoassay, Cocaine
- Regulation
- 21 CFR 862.3250
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 6
- Ingested recalls
- 0
Clearances, product code JXO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1991 | 1 |
| 1992 | 3 |
| 2012 | 1 |
| 2021 | 1 |
Applicants with the most clearances
Product code JXO| Applicant | Clearances |
|---|---|
| Psychemedics Corp. | 2 |
| Solarcare Technologies Corp,Inc. | 2 |
| Instrumentation Laboratory Co. | 1 |
| Serex, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
